BE Study of Naftifine HCL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The current study was randomized, double blind, placebo-controlled, prospective, multicenter, comparative therapeutic equivalence study. The study duration for each patient was 6 weeks: Following were the visit details. V1-Baseline and Randomization Visit (Day 1). V2- End of therapy visit (at the end of week 2 + 2 days). V3- Follow up visit (at the end of week 4 + 2 days). V4 - Test of cure visit ( at the end of week 6 + 4 days).
Epistemonikos ID: ec37c2162a05a416d868d7414b36f6fa4c955381
First added on: May 12, 2024